Effectiveness of anti-CD20 therapies after natalizumab

被引：0
|
作者：
Cunha, Carolina [1 ]
Matos, Sara [1 ]
Carvalho, Ines V. [1 ]
Cardoso, Joao [2 ]
Campelo, Isabel [2 ]
Feio, Jose [2 ]
Batista, Sonia [1 ]
Nunes, Carla [1 ]
Macario, Maria do Carmo [1 ]
Sousa, Livia Maria [1 ]
Correia, Ines [1 ]
机构：
[1] Coimbra Hosp & Univ Ctr, Neurol Dept, Coimbra, Portugal
[2] Coimbra Hosp & Univ Ctr, Hosp Pharm Dept, Coimbra, Portugal
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P723/2161
引用
收藏
页码：623 / 623
页数：1
相关论文
共 50 条
  • [1] Dental Adverse Effects of Anti-CD20 Therapies
    Bartak, Helene
    Fareh, Tasnim
    Ben Othman, Nouha
    Viard, Delphine
    Cohen, Mikael
    Rocher, Fanny
    Ewig, Elliot
    Drici, Milou-Daniel
    Lebrun-Frenay, Christine
    [J]. NEUROLOGY AND THERAPY, 2024, 13 (03) : 917 - 930
  • [2] Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal
    Fabien Rollot
    Justine Couturier
    Romain Casey
    Sandrine Wiertlewski
    Marc Debouverie
    Jean Pelletier
    Jérôme De Sèze
    Pierre Labauge
    Aurélie Ruet
    Eric Thouvenot
    Jonathan Ciron
    Eric Berger
    Olivier Gout
    Pierre Clavelou
    Bruno Stankoff
    Olivier Casez
    Bertrand Bourre
    Hélène Zephir
    Thibault Moreau
    Christine Lebrun-Frenay
    Elisabeth Maillart
    Gilles Edan
    Jean-Philippe Neau
    Alexis Montcuquet
    Philippe Cabre
    Jean-Philippe Camdessanché
    Gilles Defer
    Haifa Ben Nasr
    Aude Maurousset
    Karolina Hankiewicz
    Corinne Pottier
    Emmanuelle Leray
    Sandra Vukusic
    David-Axel Laplaud
    [J]. Neurotherapeutics, 2022, 19 : 476 - 490
  • [3] Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal
    Rollot, Fabien
    Couturier, Justine
    Casey, Romain
    Wiertlewski, Sandrine
    Debouverie, Marc
    Pelletier, Jean
    De Seze, Jerome
    Labauge, Pierre
    Ruet, Aurelie
    Thouvenot, Eric
    Ciron, Jonathan
    Berger, Eric
    Gout, Olivier
    Clavelou, Pierre
    Stankoff, Bruno
    Casez, Olivier
    Bourre, Bertrand
    Zephir, Helene
    Moreau, Thibault
    Lebrun-Frenay, Christine
    Maillart, Elisabeth
    Edan, Gilles
    Neau, Jean-Philippe
    Montcuquet, Alexis
    Cabre, Philippe
    Camdessanche, Jean-Philippe
    Defer, Gilles
    Ben Nasr, Haifa
    Maurousset, Aude
    Hankiewicz, Karolina
    Pottier, Corinne
    Leray, Emmanuelle
    Vukusic, Sandra
    Laplaud, David-Axel
    [J]. NEUROTHERAPEUTICS, 2022, 19 (02) : 476 - 490
  • [4] A personalized approach for anti-CD20 therapies in multiple sclerosis
    Hogenboom, Laura
    Kempen, Zoe L. E. van
    Kalincik, Tomas
    Bar-Or, Amit
    Killestein, Joep
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 91
  • [5] BLOCKING B-CELLS (ANTI-CD20/ANTI-CD20)
    Isenberg, David A.
    [J]. RHEUMATOLOGY, 2015, 54 : 1 - 1
  • [6] Anti-CD20 and natalizumab in highly active relapsing-remitting multiple sclerosis: the SWIFNA-20 comparative effectiveness study
    Laplaud, D. -A.
    Rollot, F.
    Casey, R.
    Wiertlewski, S.
    Pelletier, J.
    De Seze, J.
    Labauge, P.
    Ruet, A.
    Thouvenot, E.
    Ciron, J.
    Clavelou, P.
    Stankoff, B.
    Bourre, B.
    Lebrun-Frenay, C.
    Maillart, E.
    Defer, G.
    Camdessanche, J. -P.
    Maurousset, A.
    Hankiewicz, K.
    Bakchine, S.
    Montcuquet, A.
    Vukusic, S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 678 - 680
  • [7] Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
    de Seze, Jerome
    Maillart, Elisabeth
    Gueguen, Antoine
    Laplaud, David A. A.
    Michel, Laure
    Thouvenot, Eric
    Zephir, Helene
    Zimmer, Luc
    Biotti, Damien
    Liblau, Roland
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] A Comprehensive Review on the Efficacy of Anti-CD20 Therapies in Pemphigus Treatment
    Khan, Arshiya
    Singh, Adarshlata
    Madke, Bhushan
    Bhatt, Drishti M.
    Jangid, Shivani D.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [9] Anti-CD20 in lupus
    Isenberg, DA
    Leandro, MJ
    Ehrenstein, MR
    Edwards, JCW
    Manson, J
    Cambridge, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 27 - 28
  • [10] Characteristics of Patients Switching from Anti-CD20 Therapy to Natalizumab in the Treatment of Multiple Sclerosis
    Vollmer, Brandi
    Nair, Kavita
    Corboy, John
    Vollmer, Timothy
    Alvarez, Enrique
    [J]. NEUROLOGY, 2019, 92 (15)
12345